Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis
Last Updated: Friday, July 17, 2026
Data from a contemporary analysis of survival among patients with DLBCL suggests that curative-intent therapy (ie, ASCT and CAR-T) is associated with improved overall survival compared with conventional treatment approaches.
